Mon, January 10, 2022
Sun, January 9, 2022
Fri, January 7, 2022
Thu, January 6, 2022
Wed, January 5, 2022
Tue, January 4, 2022
Mon, January 3, 2022

Matthew Harrison Maintained (BLUE) at Sell with Decreased Target to $10 on, Jan 6th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-10-on-jan-6th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Sell with Decreased Target from $11 to $10 on, Jan 6th, 2022.

Matthew has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Decreased Target to $13 on, Monday, November 8th, 2021


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Salveen Richter of "Goldman Sachs" Downgraded from Hold to Strong Sell and Decreased Target to $10 on, Monday, November 8th, 2021
  • Difei Yang of "Mizuho" Maintained at Strong Buy with Decreased Target to $23 on, Wednesday, September 22nd, 2021

Publication Contributing Sources